5-R01-EB031904-04 |
Multiplexed and Logical Control of the Mammalian Transcriptome Using Cas13 |
Wilson Wong |
Boston University (Charles River Campus) |
5-R01-EB033676-03 |
Next generation transposon vectors for genome engineering |
Matthew Wilson |
Vanderbilt University Medical Center |
1-R01-EB036493-01 |
Non-invasive and Long-lived CNS Delivery of Treg-inducing Cytokine Depots |
Peter Tessier |
University of Michigan at Ann Arbor |
5-R21-EB032609-02 |
Novel optogenetic tool for noninvasive neuronal inhibition |
Mark Gomelsky |
University of Wyoming |
5-R21-EB035261-02 |
Programmable 'all-in-one' RNA as a molecular scaffold for targeted combinatorial innate immune activation |
Connie Wu |
University of Michigan at Ann Arbor |
7-R01-EB031957-04 |
Programmable gene integration and cell engineering with CRISPR-directed integrases |
Omar Abudayyeh |
Brigham And Women'S Hospital |
5-R21-EB033981-03 |
Readthrough of disease-causing nonsense mutations by targeted selenocysteine recoding |
Oded Regev |
New York University |
5-R01-EB031830-04 |
Reprogramming Exosomes for Biomedical Applications |
Yong Zhang |
University of Southern California |
1-R21-EB036277-01 |
Ribozyme-mediated killing of cells harboring cancer driver mutations |
André Leier |
University of Alabama at Birmingham |
1-R01-EB031936-01 |
Semi-synthetic, magneto-photonic circuit for non-invasive control of cellular function |
Ute Hochgeschwender |
Central Michigan University |